SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-019036
Filing Date
2022-12-29
Accepted
2022-12-29 17:01:03
Documents
88
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-K otlk-20220930x10k.htm   iXBRL 10-K 2211262
2 EX-4.1 otlk-20220930xex4d1.htm EX-4.1 47279
3 EX-10.38 otlk-20220930xex10d38.htm EX-10.38 50824
4 EX-21.1 otlk-20220930xex21d1.htm EX-21.1 5303
5 EX-23.1 otlk-20220930xex23d1.htm EX-23.1 2834
6 EX-31.1 otlk-20220930xex31d1.htm EX-31.1 13544
7 EX-31.2 otlk-20220930xex31d2.htm EX-31.2 13962
8 EX-32.1 otlk-20220930xex32d1.htm EX-32.1 12777
9 GRAPHIC otlk-20220930x10k006.jpg GRAPHIC 26358
10 GRAPHIC otlk-20220930x10k007.jpg GRAPHIC 49932
11 GRAPHIC otlk-20220930x10k008.jpg GRAPHIC 51929
  Complete submission text file 0001558370-22-019036.txt   9258905

Data Files

Seq Description Document Type Size
12 EX-101.SCH otlk-20220930.xsd EX-101.SCH 51672
13 EX-101.CAL otlk-20220930_cal.xml EX-101.CAL 58407
14 EX-101.DEF otlk-20220930_def.xml EX-101.DEF 263739
15 EX-101.LAB otlk-20220930_lab.xml EX-101.LAB 450484
16 EX-101.PRE otlk-20220930_pre.xml EX-101.PRE 428013
82 EXTRACTED XBRL INSTANCE DOCUMENT otlk-20220930x10k_htm.xml XML 1469715
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 221499406
SIC: 2836 Biological Products, (No Diagnostic Substances)